000 01569 a2200493 4500
005 20250517101607.0
264 0 _c20170512
008 201705s 0 0 eng d
022 _a1931-3543
024 7 _a10.1016/j.chest.2016.06.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTolppanen, Anna-Maija
245 0 0 _aAntipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease.
_h[electronic resource]
260 _bChest
_cDec 2016
300 _a1233-1241 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlzheimer Disease
_xcomplications
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aComorbidity
650 0 4 _aCross-Over Studies
650 0 4 _aFemale
650 0 4 _aFinland
_xepidemiology
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPneumonia
_xmortality
650 0 4 _aPropensity Score
650 0 4 _aRisk Factors
650 0 4 _aSocioeconomic Factors
700 1 _aKoponen, Marjaana
700 1 _aTanskanen, Antti
700 1 _aLavikainen, Piia
700 1 _aSund, Reijo
700 1 _aTiihonen, Jari
700 1 _aHartikainen, Sirpa
700 1 _aTaipale, Heidi
773 0 _tChest
_gvol. 150
_gno. 6
_gp. 1233-1241
856 4 0 _uhttps://doi.org/10.1016/j.chest.2016.06.004
_zAvailable from publisher's website
999 _c26121184
_d26121184